ReviewCancer cell international2021
Recombinant immunotoxins development for HER2-based targeted cancer therapies.
Reza Mahmoudi et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
10 papers cite it
this papercites it
ReviewCancer cell international2021
Reza Mahmoudi et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.